Shares, which ended 2020 at $1.32, soared to a high of $6 on Feb. 12, for a gain of more than 350% in a matter of weeks. That’s when the Reddit-fueled short squeeze chatter was in full effect. Somehow ...

-- Additional Lines Expand Company’s Portfolio and Include Telehealth Capable Stroke Rehabilitation Devices as well as Clinic and Home Use Devices for Persons with Spinal Cord Injury -- “The addition ...

"As proud pioneers in this industry, gaining Provider status is an important next step for improving access to our Personal Exoskeleton," said Larry Jasinski, ReWalk CEO. "However, accreditation does ...

When Shacey Petrovic stepped down as CEO of Acton medical-device company Insulet in May for personal reasons, she left Central Massachusetts without a single public company headquartered here, traded ...

Rewalk Robotics LFWD is preparing to release its quarterly earnings on Thursday, 2025-08-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

The value of ReWalk's equity has dropped sharply over the last four months, primarily from dilution. ReWalk has maxed out it available credit from Kreos Capital and is in danger of being de-listed ...

Late in October, shares of ReWalk Robotics (RWLK) took quite a tumble as the company disclosed a public offering, pricing 3.25 million units at $3.75 each, while shares were trading above $5.00 each.

Since going public about seven years ago, shares in ReWalk Robotics, a Marlborough, Massachusetts-based robotic exoskeleton provider, had plummeted about 99.7% as of September 24. But this week, ...

The Dow Jones closed lower by around 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...

Lifeward had a second executive join its C-suite transition in two months as the Marlborough-based medical device has selected its new CFO. Lifeward mobility products will be available in six new ...